Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Silence of the LAM

C. S. H. Ng, S. Wan, I. Y. P. Wan, M. J. Underwood
European Respiratory Journal 2008 32: 522-523; DOI: 10.1183/09031936.00050608
C. S. H. Ng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Wan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Y. P. Wan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. J. Underwood
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

We read with interest the article by Warth et al. 1 on mediastinal angiomyolipoma and tuberous sclerosis. Apart from mediastinal angiomyolipoma, lymphangioleiomyomatosis (LAM) can occur as part of the genetic condition tuberous sclerosis 2. Since the first report by Cornog and Eterline 3, LAM has been increasingly studied for the pathological processes involved in atypical smooth muscle LAM cell proliferation. However, it has been difficult to gain complete understanding of the natural history of LAM due to its rarity. LAM tends to progress slowly and ultimately leads to respiratory failure. Nevertheless, the clinical course of patients with LAM can vary, with 10 yr survival between 10–60% 2. Some patients survive for 20 yrs following presentation 2. LAM may remain silent until spontaneous pneumothorax occurs, which is the most frequently presenting symptom 4. The indications for pleurodesis in this condition are not well established. In our experience, surgical pleurodesis is usually recommended for patients with recurrent or spontaneous bilateral pneumothoraces, but higher rates of recurrence can be expected for this group of patients 4. In addition, pleural symphysis following surgical pleurodesis may make future lung transplantation impossible. Multiple diffuse blebs may be seen intraoperatively (fig. 1⇓), alerting the clinician towards this condition.

Fig. 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1—

Intraoperative video-assisted thoracic surgery view of lymphangioleiomyomatosis on the surface of lung.

Classically, a computed tomography (CT) scan shows multiple thin-walled cysts distributed throughout both lungs, although unilateral lung involvement has been described 5. A CT scan can also help to detect other unsuspecting pathology 6. Pathological examination is required for confirmation of LAM, which can be obtained by transbronchial, percutaneous or surgical biopsy. We advocate video-assisted thoracic surgery biopsy with excision of any bleb and culprit lesion, particularly in the case of associated pneumothorax. The lung is characterised by cystic changes associated with proliferation of atypical smooth muscle cells (LAM cells), which can involve bronchioles, vessels and airspaces explaining, in part, the occurrence of pneumothorax, chylothorax and haemoptysis in these patients. (fig. 2⇓) Positive HMB-45 immunostaining and the presence of oestrogen and progesterone receptors are also characteristics of LAM. Despite reports of various therapeutic regimens, none offer a consistently effective response. Corticosteroids and cytotoxic agents usually provide little benefit. Medical hormonal therapy (progesterone, tamoxifen, luteinising hormone-releasing hormone agonist) and surgical hormonal therapy (oophorectomy, ovarian radiofrequency ablation) have been used with variable responses 7.

Fig. 2—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2—

Histopathology section showing blood-filled cystic spaces with fascicular spindle cells (lymphangioleiomyomatosis cells) and vascular congestion. Interstitial proliferation (vascular and bronchial) and sub-pleural proliferation is also seen.

For end-stage lymphangioleiomyomatosis, lung transplantation can be an effective treatment option, but recurrences in the transplanted lung may occur following lymphangioleiomyomatosis cell migration 7.

Statement of interest

None declared.

    • © ERS Journals Ltd

    References

    1. ↵
      Warth A, Herpel E, Schmähl A, et al. Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis. Eur Respir J 2008;31:678–680.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Johnson SR, Whale CI, Hubbard RB, Lewis SA, Tattersfield AE. Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 2004; 59; 800–803.
    3. ↵
      Cornog JL Jr, Enterline HT. Lymphangiomyoma, a benign lesion of chyliferous lymphatics synonymous with lymphangiopericytoma. Cancer 1966;19:1909–1930.
      OpenUrlCrossRefPubMedWeb of Science
    4. ↵
      Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med 1990;323:1254–1260.
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      Avila NA, Chen CC, Chu SC, et al. Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests. Radiology 2000;214:441–446.
      OpenUrlPubMedWeb of Science
    6. ↵
      Ng CS, Wan S, Lee TW, Yim AP. Cystic lesions of the lung: a forgotten menace. Eur Respir J 2005;26:748–749.
      OpenUrlFREE Full Text
    7. ↵
      Taveira-Da Silva AM, Stylianou MP, Hedin CJ, Hathaway O, Moss J. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest 2004;126:1867–1874.
      OpenUrlCrossRefPubMedWeb of Science
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 32 Issue 2 Table of Contents
    European Respiratory Journal: 32 (2)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Silence of the LAM
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Silence of the LAM
    C. S. H. Ng, S. Wan, I. Y. P. Wan, M. J. Underwood
    European Respiratory Journal Aug 2008, 32 (2) 522-523; DOI: 10.1183/09031936.00050608

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Silence of the LAM
    C. S. H. Ng, S. Wan, I. Y. P. Wan, M. J. Underwood
    European Respiratory Journal Aug 2008, 32 (2) 522-523; DOI: 10.1183/09031936.00050608
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Statement of interest
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Latent COPD: a proposed new term in the disease nomenclature
    • Empiric anti-anaerobic antibiotics are associated with adverse clinical outcomes
    • Anti-anaerobic antibiotics: indication is key
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society